SCHEMBL10035932

SCHEMBL10035932

CCCN(CCCC=O)c1ccc([N+](=O)[O-])cc1OC

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH3A1 P30838 1/20 0.45
HTT P42858 3/20 0.44
CYP19A1 P11511 4/20 0.42
TDP1 Q9NUW8 1/20 0.40
HCAR3 P49019 1/20 0.39
ALDH1A1 P00352 6/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 1/20 0.38
PKM P14618 1/20 0.38
TP53 P04637 1/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7470964 0.77 HTT (0.53) HTTCYP19A1TDP1ALDH1A1CYP1A2
SCHEMBL7466490 0.77 HTT (0.53) HTTCYP19A1TDP1ALDH1A1CYP1A2
SCHEMBL6929818 0.73 ALDH3A1 (0.58) ALDH3A1HTTCYP19A1HCAR3ALDH1A1
SCHEMBL10024461 0.73 ALDH1A1 (0.57) HTTHCAR3ALDH1A1CYP1A2CYP3A4
SCHEMBL23499834 0.72 MAPT (0.55) HTTCYP19A1TDP1ALDH1A1CYP1A2
SCHEMBL27864377 0.72 HTT (0.55) HTTCYP19A1TDP1ALDH1A1CYP1A2
SCHEMBL6395129 0.71 ALDH3A1 (0.67) ALDH3A1HTTCYP19A1TDP1HCAR3
Propionaldehyde SCHEMBL28103120 0.71 CYP19A1 (0.59) HTTCYP19A1TDP1ALDH1A1CYP1A2
SCHEMBL16994101 0.71 ALDH1A1 (0.60) HTTTDP1ALDH1A1CYP1A2CYP3A4
SCHEMBL10878837 0.71 HTT (0.62) HTTCYP19A1TDP1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012053606-A1 ARYLAMINOHETEROCYCLIC CARBOXAMIDE COMPOUND アステラス製薬株式会社 (JP) 2012-04-26 WO disclosed